U.S. Congress legislation · 119th Congress
HB10531: Sickle Cell Disease Treatment Centers Act of 2026
Status: In committee, September 24, 2026
To establish a program to address sickle cell disease and other heritable hemoglobinopathies.
What the bill says
To establish a program to address sickle cell disease and other heritable hemoglobinopathies.
From the introduced text, September 24, 2026:
A BILL To establish a program to address sickle cell disease and other heritable hemoglobinopathies. SECTION 1. Short title This Act may be cited as the Sickle Cell Disease Treatment Centers Act of 2026 . SECTION 2. Establishment of sickle cell disease and other heritable hemoglobinopathies treatment centers Subpart I of part D of title III of the Public Health Service Act ( 42 U.S.C. 254b et seq. ) is amended by inserting after section 330P ( 42 U.S.C. 254c-22 ) the following: SECTION 330Q. Sickle cell disease and other heritable hemoglobinopathies treatment centers (a) Definitions In this section: (1) Community-based organization The term community-based organization means a community-based nonprofit organization. (2) Hub-and-spoke network The term hub-and-spoke network means a system for delivery of health care services-- (A) in which a medical hub identifies and manages a medical spoke or network of spokes, to provide comprehensive sickle cell disease care; (B) in which such entities serving as spokes-- (i) may provide sickle cell disease care services; and (ii) may increase services over time to meet the definition of medical hubs and connect with new spokes; and (C) in which the medical hub and spoke has a partnership with one or more community-based organizations to extend services and outreach to the sickle cell disease community. (3) Medical hub The term medical …
Sponsors
- Alma Adams (D, HD-012) · primary sponsor
- Danny Davis (D, HD-IL-7)
- Glenn Ivey (D, HD-004)
Latest actions
- : Referred to the House Committee on Energy and Commerce.
- : Introduced in House
Subjects: Health
Common questions
- What is HB10531?
- HB10531 is a bill in Congress (119th Congress): Sickle Cell Disease Treatment Centers Act of 2026.
- What does HB10531 do?
- In its own words: To establish a program to address sickle cell disease and other heritable hemoglobinopathies.
- What is the status of HB10531?
- In committee as of September 24, 2026. Latest action: Referred to the House Committee on Energy and Commerce. (September 24, 2026).
- Who sponsored HB10531?
- Alma Adams (D, HD-012), with 2 co-sponsors.
- Where is the official record for HB10531?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/10531
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.